News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Spectranetics Corporation Announces Director Retirement
June 7, 2006
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
COLORADO SPRINGS, Colo., June 7 /PRNewswire-FirstCall/ -- Spectranetics Corporation (Nasdaq: SPNC - News) announced today that Cornelius C. Bond, Jr., 72, is retiring from the Board following 20 years of service.
Twitter
LinkedIn
Facebook
Email
Print
People
MORE ON THIS TOPIC
Business
Gossamer regains rights to lung disease asset from Chiesi after Phase 3 fail
July 27, 2026
·
3 min read
·
Gabrielle Masson
C-suite
Sarepta names former AbbVie R&D exec Michael Severino as next CEO
July 27, 2026
·
3 min read
·
Annalee Armstrong
Earnings
AstraZeneca has no plans to ramp up dealmaking in wake of Wainua failure
July 27, 2026
·
3 min read
·
Tristan Manalac
Mergers & acquisitions
Argenx deepens immuno expertise with $2.2B Forte Biosciences buy
July 27, 2026
·
2 min read
·
Tristan Manalac
